Anti-RAG1 antibody [EPRAGR1]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal RAG1 antibody. Suitable for WB and reacts with Mouse samples. Cited in 8 publications.
View Alternative Names
V(D)J recombination-activating protein 1, RAG-1, Rag1
- WB
Supplier Data
Western blot - Anti-RAG1 antibody [EPRAGR1] (AB172637)
All lanes:
Western blot - Anti-RAG1 antibody [EPRAGR1] (ab172637) at 1/1000 dilution
All lanes:
Mouse thymus lysate at 10 µg
Predicted band size: 119 kDa
false
Related conjugates and formulations (1)
-
Anti-RAG1 antibody [EPRAGR1] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The recombination process performed by RAG1 is integral to generating the diversity of antibodies and T-cell receptors which form the foundation of the adaptive immune system. RAG1 acts as part of a protein complex with RAG2 where it collaborates to recognize and bind to recombination signal sequences in the DNA. This complex facilitates the accurate cleavage necessary for recombination enabling lymphocytes to produce a wide variety of receptors capable of recognizing numerous antigens.
Pathways
RAG1 directly participates in the antigen receptor rearrangement pathway which is fundamental to the adaptive immune system. It is closely linked to the DNA repair mechanisms required for joining the broken DNA ends it creates. Key proteins involved in these pathways include RAG2 which forms a complex with RAG1 and the DNA-dependent protein kinase which mediates the repair of DNA double-strand breaks ensuring genomic stability during immune cell development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:2194 PubMed38467629
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36675119
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6954 PubMed36376298
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer communications (London, England) 41:1116-1136 PubMed34699692
2021
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 218: PubMed34033676
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 48:3553-3566 PubMed32086526
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 9:2426 PubMed30483245
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biology 38: PubMed29760281
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com